檢索結果 - Eva González‐Barca
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
-
2
Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients 由 Carlota Gudiol, Marta Bodro, Antonella F. Simonetti, Fé Tubau, Eva González‐Barca, M. Cisnal, Eva Domingo‐Domènech, Laura Jiménez, Jordi Carratalà
出版 2012Artigo -
3
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus‐associated diffuse large B‐cell lymphoma: r... 由 Josep‐María Ribera, Albert Oriol, Mireia Morgades, Eva González‐Barca, Pilar Miralles, Armando López‐Guillermo, Santiago Gardella, Andrés López, Eugènia Abella, Marta García
出版 2007Artigo -
4
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study 由 Eric Van Den Neste, Bruno Cazin, Ann Janssens, Eva González‐Barca, María José Terol, Vincent Lévy, Jaime Pérez de Oteyza, Pierre Zachée, Andrew Saunders, Mercè de Frías, Clara Campàs
出版 2012Artigo -
5
HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era 由 Maria João Baptista, Olga García, Mireia Morgades, Eva González‐Barca, Pilar Miralles, Armando López‐Guillermo, Eugènia Abella, Miriam Moreno, Juan‐Manuel Sancho, Evarist Feliú, Josep‐María Ribera, José‐Tomás Navarro
出版 2015Artigo -
6
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma 由 Anas Younes, Gilles Salles, Giovanni Martinelli, R. Gregory Bociek, Dolores Caballero Barrigón, Eva González‐Barca, Mehmet Turgut, John F. Gerecitano, O Kong, Chaitali Babanrao Pisal, Ranjana Tavorath, Won Seog Kim
出版 2017Artigo -
7
Cause of death and prognosis of patients (pts) with primary refractory disease, and prognosis of pts reaching PFS24: Descriptive analysis of POLARIX 由 Charles Herbaux, Sascha Dietrich, Andrew McMillan, Catherine Thiéblemont, Eva González‐Barca, Antonio Pinto, Laura Fogliatto, Matthew J. Matasar, C. Lee, J. Hernandez, J. Hirata, Rodrigo Shimabukuro Ho, Aino Launonen, Frédéric Boissard
出版 2023Artigo -
8
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease 由 Eva González‐Barca, Eva Domingo‐Domènech, F.J. Capote, José Gómez‐Codina, Antonio Salar, Alicia Bailén, Josep‐María Ribera, A. J. Grillo Lopez, Javier Briones, Andrés Muñoz, Maite Encuentra, Alberto Fernández de Sevilla
出版 2007Artigo -
9
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy 由 Lourdes Martín‐Martín, Júlia Almeida, Helena Pomares, Eva González‐Barca, Pilar Bravo, Teresa Giménez, Cecilia Heras, J. A. Queizan, Elena Pérez‐Ceballos, Violeta Martínez, Natalia Alonso, Carlota Calvo, Rodolfo Álvarez, Marı́a Dolores Caballero, Alberto Órfão
出版 2016Artigo -
10
AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells 由 Antonio F. Santidrián, Diana M. González‐Gironès, Daniel Iglesias‐Serret, Llorenç Coll-Mulet, Ana M. Cosialls, Mercè de Frías, Clara Campàs, Eva González‐Barca, Esther Alonso, Verena Labi, Benoı̂t Viollet, Adalberto Benito, Gabriel Pons, Andreas Villunger, Joan Gil
出版 2010Artigo -
11
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study 由 Gilles Salles, Johannes Duell, Eva González‐Barca, Olivier Tournilhac, Wojciech Jurczak, Anna Marina Liberati, Zsolt Nagy, Aleš Obr, Gianluca Gaïdano, Marc André, Nagesh Kalakonda, Martin Dreyling, Johannes Weirather, Maren Dirnberger‐Hertweck, Sumeet Ambarkhane, Günter Fingerle‐Rowson, Kami J. Maddocks
出版 2020Artigo -
12
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma 由 Pier Luigi Zinzani, Lionel Karlin, John Radford, Dolores Caballero, Paul Fields, Martine E.D. Chamuleau, Francesco d’Amore, Corinne Haïoun, Catherine Thiéblemont, Eva González‐Barca, Coralith García, Peter Johnson, Gustaaf W. van Imhoff, Tony Ng, Karen M. Dwyer, F. Morschhauser
出版 2016Carta -
13
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study 由 Lale Kostakoglu, Federico Mattiello, Maurizio Martelli, Laurie H. Sehn, David Belada, Chiara Ghiggi, Neil Chua, Eva González‐Barca, Xiaonan Hong, Antonio Pinto, Yuankai Shi, Yoichi Tatsumi, Christopher R. Bolen, Andrea Knapp, Gila Sellam, Tina Nielsen, Deniz Şahin, Umberto Vitolo, Marek Trněný
出版 2021Artigo -
14
Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication 由 Francesc Bosch, Ana Ferrer, Neus Villamor, Marcos González, Javier Briones, Eva González‐Barca, Eugènia Abella, Santiago Gardella, Lourdes Escoda, Elena Pérez‐Ceballos, Antoni Asensi, Ma José Sayas, Carme Font, Albert Altés, Ana Muntañola, Paola Bertazzoni, Marı́a Rozman, Marta Aymerich, Eva Giné, Emili Montserrat
出版 2008Artigo -
15
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study 由 Alejandro Martı́n, E. Condé, Montserrat Arnán, Miguel Canales, Guillermo Debén, Juan‐Manuel Sancho, Rafael Andreu, Antonio Salar, Paula García Sánchez, Lourdes Vázquez, Sara Nistal, M.J. Requena, Eva Donato, Javier Gonzalez, Antonio Léon, Camilo Ruiz, Carlos Grande, Eva González‐Barca, Marı́a Dolores Caballero
出版 2008Artigo -
16
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA 由 Lale Kostakoglu, Maurizio Martelli, Laurie H. Sehn, David Belada, Angelo-Michele Carella, Neil Chua, Eva González‐Barca, Xiaonan Hong, Antonio Pinto, Yuankai Shi, Yoichi Tatsumi, Andrea Knapp, Federico Mattiello, Tina Nielsen, Deniz Şahin, Gila Sellam, Mikkel Z. Oestergaard, Umberto Vitolo, Marek Trněný
出版 2021Artigo -
17
Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia 由 Francesc Bosch, Pau Abrisqueta, Neus Villamor, María José Terol, Eva González‐Barca, Christelle Ferrà, Marcos González, Eugènia Abella, Julio Delgado, Félix Carbonell, José Antonio García Marco, Lourdes Escoda, Secundino Ferrer, Encarnación Monzó, Yolanda González, Cristina Estany, Isidro Jarque, Olga Salamero, Ana Muntañola, Emili Montserrat
出版 2009Artigo -
18
Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma 由 Johannes Duell, Kami J. Maddocks, Eva González‐Barca, Wojciech Jurczak, Anna Marina Liberati, Sven de Vos, Zsolt Nagy, Aleš Obr, Gianluca Gaïdano, Pau Abrisqueta, Nagesh Kalakonda, Marc André, Martin Dreyling, Tobias Menne, Olivier Tournilhac, Marinela Augustin, Andreas Rosenwald, Maren Dirnberger‐Hertweck, Johannes Weirather, Sumeet Ambarkhane, Gilles Salles
出版 2021Artigo -
19
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy 由 Alexandra Valera, Armando López‐Guillermo, Teresa M. Cardesa‐Salzmann, Fina Climent, Eva González‐Barca, Santiago Mercadal, I Espinosa, Silvana Novelli, Javier Briones, José Luís Mate, Olga Salamero, Juan‐Manuel Sancho, Leonor Arenillas, Sérgio Serrano, Nadina Erill, Daniel Martı́nez, Paola Castillo, Jordi Rovira, Antonio Martı́nez, Elı́as Campo, Luís Colomo
出版 2013Artigo -
20
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy 由 Gonzalo Gutiérrez, Teresa M. Cardesa‐Salzmann, Fina Climent, Eva González‐Barca, Santiago Mercadal, José Luís Mate, Juan‐Manuel Sancho, Leonor Arenillas, Sergi Serrano, Lourdes Escoda, S. Martínez, Alexandra Valera, Antonio Martı́nez, Pedro Jares, Magdalena Pinyol, Adriana García‐Herrera, Alejandra Martínez‐Trillos, Eva Giné, Neus Villamor, Elı́as Campo, Luís Colomo, Armando López‐Guillermo
出版 2011Artigo
相關主題
Medicine
Internal medicine
Lymphoma
Oncology
Rituximab
Chemotherapy
Immunology
Diffuse large B-cell lymphoma
Biology
Gastroenterology
Cyclophosphamide
Cancer research
Chronic lymphocytic leukemia
Leukemia
Neutropenia
Surgery
Pathology
Adverse effect
Antibody
B cell
Clinical endpoint
Clinical trial
Gene
Genetics
International Prognostic Index
Refractory (planetary science)
Astrobiology
CHOP
Fludarabine
Gene expression